Lithuanian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
hypogonadism/phosphatase
Nuoroda įrašoma į mainų sritį
Puslapis 1 nuo 69 rezultatus
The relationship between periodontal status and alkaline phosphatase levels in gingival crevicular fluid in men with hypergonadotropic hypogonadism.
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
OBJECTIVE
The aim of this preliminary study was to determine the possible relationship between alkaline phosphatase (ALP) levels in the gingival crevicular fluid (GCF) and periodontal disease in men with hypergonadotropic hypogonadism (HH).
METHODS
A total of 41 patients were divided into four
The effect of hypogonadism and testosterone-enhancing therapy on alkaline phosphatase and bone mineral density.
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
OBJECTIVE
To evaluate the relationship of testosterone-enhancing therapy on alkaline phosphatase (AP) in relation to bone mineral density (BMD) in hypogonadal men.
METHODS
Retrospective review of 140 men with testosterone levels of <350 ng/dL undergoing testosterone-enhancing therapy and followed
A critical estimation of the effect of chorionic gonadotropic hormone treatment on male hypogonadism by prostatic production of acid phosphatase.
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
On the mark? Is alkaline phosphatase a surrogate for bone density in men with hypogonadism?
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Elevated serum receptor activator of nuclear factor kappa B ligand and osteoprotegerin levels in late-onset male hypogonadism.
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
OBJECTIVE
Studies that analyze the levels of osteoprotegerin (OPG) or receptor activator of nuclear factor kappa B ligand (RANKL) in hypogonadal men, the majority of whom have prostate cancer or are undergoing androgen-deprivation therapy, are few and inconclusive.
METHODS
81 men aged 69.3 ± 0.8
Factors of mineral homeostasis impairment and bone mineral density loss in women with central hypogonadism
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Objective: The aims of the study were to estimate markers of mineral turnover and bone mineral density (BMD) in young women with central hypogonadism (CH) in comparison with healthy young and postmenopausal women, and to reveal the possible impact of different factors on BMD.Method: We
Male Hypogonadism Causes Obesity Associated with Impairment of Hepatic Gluconeogenesis in Mice.
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
The steroid hormones synthesized by the male gonads play diverse roles in biological processes. Androgens, the primary hormones produced by the male gonads, are key regulators of fat homeostasis, hence androgen-deprivation therapies often induce obesity. However, the molecular mechanism by which
Treatment of isolated hypogonadotropic hypogonadism effect on bone mineral density and bone turnover.
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Isolated hypogonadotropic hypogonadism (IHH) presents with delayed puberty in the late teens or early twenties, with a period of testosterone deficiency during active growth. The aims of the study were to determine 1) whether long term treatment of IHH results in normalization of bone density (BMD)
Bone loss following hypogonadism in men with prostate cancer treated with GnRH analogs.
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
It is known that bone mineral density (BMD) is low in men who are hypogonadal. However, the rate and sites of bone loss following testosterone deficiency are not known. The resulting hypogonadism after GnRH analog therapy for the treatment of prostate cancer allows us to examine bone loss and bone
Spurious testosterone laboratory results in a patient taking synthetic alkaline phosphatase (asfotase alfa).
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
OBJECTIVE
We report a case of discordant total and free testosterone values in a patient with hypogonadism and juvenile hypophosphatasia after he initiated treatment with asfotase alfa, recombinant tissue non-specific alkaline phosphatase.
METHODS
Total testosterone was evaluated using immunoassay
Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism.
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Acquired hypogonadism is being increasingly recognized in adult men. However, the effects of long term testosterone replacement on bone density and body composition are largely unknown. We investigated 36 adult men with acquired hypogonadism (age, 22-69 yr; median, 58 yr), including 29 men with
Hip fracture in elderly men: the importance of subclinical vitamin D deficiency and hypogonadism.
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
OBJECTIVE
To determine the major risk factors for hip fracture in elderly men.
METHODS
Prospective recruitment, followed by analysis of clinical and biochemical variables.
METHODS
Men aged 60 years and older who presented to St George Hospital (a 650-bed tertiary-care centre) in 1995, comprising all
Bone loss in young women with primary hypogonadism and its prevention with calcitonin.
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
A total of 63 healthy young women with primary amenorrhea, 37 control women at the same age with normal ovarian function and 118 postmenopausal women underwent bone mineral density (BMD) measurements at the lumbar spine (L2-L4) by dual photon absorptiometry. Mean +/- SE BMD value in the primary
Rutin ameliorates carbon tetrachloride (CCl4)-induced hepatorenal toxicity and hypogonadism in male rats.
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Rutin, a food derived-polyphenolic bioflavonoid, has been acknowledged for several health benefits. This study aims to explore the ameliorative effects of rutin against carbon tetrachloride (CCl4) toxicity in male rats. Adult male rats were given either CCl4 (30% in olive oil,
Increased hepatic steatosis and insulin resistance in mice lacking hepatic androgen receptor.
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Early studies demonstrated that whole-body androgen receptor (AR)-knockout mice with hypogonadism exhibit insulin resistance. However, details about the mechanisms underlying how androgen/AR signaling regulates insulin sensitivity in individual organs remain unclear. We therefore generated hepatic
Išsamiausia vaistinių žolelių duomenų bazė, paremta mokslu
- Dirba 55 kalbomis
- Žolelių gydymas, paremtas mokslu
- Vaistažolių atpažinimas pagal vaizdą
- Interaktyvus GPS žemėlapis - pažymėkite vaistažoles vietoje (netrukus)
- Skaitykite mokslines publikacijas, susijusias su jūsų paieška
- Ieškokite vaistinių žolelių pagal jų poveikį
- Susitvarkykite savo interesus ir sekite naujienas, klinikinius tyrimus ir patentus
Įveskite simptomą ar ligą ir perskaitykite apie žoleles, kurios gali padėti, įveskite žolę ir pamatykite ligas bei simptomus, nuo kurių ji naudojama.
* Visa informacija pagrįsta paskelbtais moksliniais tyrimais
